Can a treat-to-target strategy achieve better outcomes for patients with spondyloarthritis? Insights from the latest data.
Fracture & an Aging World
Insights into osteoporosis treatments as societies around the world age.
A Long Path Forward: Complications of COVID-19 in Patients with Rheumatic Disease
Emerging evidence shows COVID-19 infection may have long-term consequences, such as arthritis onset and more.
Plan Ahead: Clinical Tips for Managing Reproductive Health in Patients with Rheumatic Disease
Dr. May Ching Soh highlighted practical approaches when caring for pregnant patients with rheumatic disease.
Axial Spondyloarthritis: Research that Matters
Axial spondyloarthritis (axSpA), comprising ankylosing spondylitis (AS) and nonradiographic axial SpA, is the main form of chronic inflammatory arthritis affecting the axial skeleton. What research in axial spondyloarthrits to be presented at ACR Convergence 2024 has the greatest potential for a positive impact on clinical care, treatment options or serve as the basis for future…
Anti-Infliximab Antibodies Predict Response in Axial Spondyloarthritis
Pimentel et al. evaluated the influence of anti-infliximab antibodies on patients with axial spondyloarthritis. The researchers found that anti-infliximab antibodies were associated with decreased infliximab performance and difficulty tapering its dosage, as well as a good clinical response to a second, alternate tumor necrosis factor inhibitor.
Lupus: Closer to a Cause?
Two studies outline the roles of air pollution and T cell imbalance in the pathogenesis of systemic lupus erythematosus.
B Cell-Depleting Therapy in SLE
“SLE has long been a disease with many clinical manifestations but few treatment options,” says Physician Editor Bharat Kumar, explaining why he thinks this article is a must-read. “That’s rapidly changing with advances in our knowledge of lupus, especially in the role of B-cells in triggering the onset and perpetuating disease activity of lupus.”
An Expert’s Take on the Best Research in RA to Be Presented at ACR Convergence 2024
With thousands of research abstracts and posters being presented at ACR Convergence 2024, Nov. 14–19, at the Walter E. Washington Convention Center in Washington, D.C., figuring out which research is important today, which could prove important in the future, what has the potential to affect clinical care or prove the basis for future research is…
Updates in RA-Associated ILD
On Sunday, Nov. 17, at ACR Convergence 2024, three speakers will deliver a presentation on Rheumatoid Arthritis-Associated Interstitial Lung Disease: Advances in Screening, Diagnosis and Patient Phenotyping. This session will have three 20-minute presentations that cover distinct aspects of RA-associated ILD from early identification of ILD through high-resolution computed tomography (HRCT) text mining, to phenotyping…
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 344
- Next Page »